Professional Documents
Culture Documents
Nanotechnology
Nanotechnology
Submitted to
By:
MARIBETH J. CUSAP
JOYBIE LOAYON
MST-SciEd
THE USE OF NANOTECHNOLOGY IN THE TREATMENT OF DIABETES
Diabetes is the eighth driving reason for death in the Philippines, with 3.7 million
cases in the most recent year alone. What's more, at the momentum rate Filipinos are
building up the disease, the International Diabetes Federation evaluates that the
Philippines might be among the top 10 nations with the most instances of the sickness by
2045. Diabetes, basically, is a metabolism disorder described by lacking the creation or
use of insulin by the body, bringing about expanded sugar levels in the blood and pee.
Left unchecked, the results can incorporate long haul harm and disappointment of organs,
particularly the eyes, kidneys, nerves, veins, and appendages. (Ku & Kegels, 2013)
There are two kinds of diabetes: Type 1, in which the body's safe framework
assaults the cells that produce insulin; and the more typical Type 2, where the body's
cells don't create enough insulin or don't respond to the insulin. Diabetes, especially Type
2 can be moderated from the get-go—or forestalled completely—with a solid way of life.
(Mayfield, 1998)
Source: https://www.researchgate.net/figure/3-Mortality-Rate-from-Diabetes-Mellitus-
Philippines-2008-2013_fig30_319998833
1.0 Definition of Nanotechnology
treatment.
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478103/#!po=7.35294
The great conductivity and synergist capacity of nanoscale carbon structures has
prompted their utilization in an assortment of glucose detecting modalities (Barone et.al,
2005) (Li et.al, 2003). Moreover, electrically coupling glucose oxidase to nanoscale
carbon structures regulates the electrical opposition of the structures (Besteman et.al,
2003). The first to distribute look into on utilizing a solitary carbon nanotube as a biosensor
was Besteman, et al., who immobilized GOx on a semiconductor carbon nanotube by
means of 1-pyrenebutanoic corrosive succinimidyl ester, and found that the conductivity
of the nanotube was associated to the movement of the immobilized GOx's reaction to
the expansion of glucose. The expansion of 0.1 mM glucose arrangement brought about
a surmised 10% expansion in the conductivity of the GOx-nanotube complex. The
framework likewise showed a solid affectability to the pH of the encompassing solution
(Besteman et.al, 2004)
Figure 2: Experiment of Yang et.al on improving the sensitivity of glucose sensors
Another strategy for typifying islet cells is the Layer by Layer (LbL) deposition of a
semi-permeable film onto the cells (Pickup, 2008). A relentless test of utilizing LbL
testimony for islet cell epitome is maintaining a strategic distance from the utilization of
polyionic polymers, which are cytotoxic (Teramura et.al, 2008) (Wilson et.al, 2011).
Elective restricting methodologies are expected to make LbL coatings on the cells that
have expanded strength and diminished cytotoxicity. As of late, Gattas-Asfura and
associates detailed another LbL method using interpolymeric covalent connecting to
improve the strength of the LbL coatings (Gatas Asfura et.al, 2013) Alginate and
poly(amidoamine) (PAMAM) dendrimers were functionalized with corresponding
Staudinger ligation gatherings: azide and methyl 2-(diphenylphosphino) terephthalate.
Covalent linkages and electrostatic forces between the films expanded the dependability
and thickness of the resultant bilayer. This bioorthogonal functionalization strategy for
interpolymeric connecting likewise fills in as a technique for functionalizing the outside of
the islet and can be adjusted to incorporate auxiliary helpful operators, for example,
immunosuppressant drugs or bioactive gatherings that upgrade the nutrient.
Artificial shut circle frameworks are frequently portrayed by their strategy for
glucose identification. Glucose can be distinguished through enzymatic strategies utilizing
compounds, for example, glucose oxidase (GOx), Binding of glucose to manufactured
gatherings, for example, those in Phenylboronic corrosive (PBA), or official to glucose
restricting proteins, for example, Concavalin A (Con A)
6.1 Glucose Binding Protein (GBP) Systems
Source: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 Jul; 7(4): 548–564.
Researches on Diabetes Mellitus must focus on the three pillars of its treatment.
Nanotechnology has therefore proved significant tools in much precise data on diagnosis
on the glucose level including the automatic regulation and injection of insulin to help aid
the dysfunctional organ and cells in the body. It is therefore important to conduct a clinical
study on the actual people in assessing the efficacy of the method. Also, studies on its
side effects should also be conducted in order to avoid or minimize health risks that may
arise due to the use of the method.
8.0 References
Barone PW, Baik S, Heller DA, Strano MS. Near-infrared optical sensors based on single-
walled carbon nanotubes. Nature Materials. 2005;4:86–92.
Besteman K, Lee J-O, Wiertz FGM, Heering HA, Dekker C. Enzyme-Coated Carbon
Nanotubes as Single-Molecule Biosensors. Nano Letters. 2003;3:727–730
Bratlie KM, York RL, Invernale MA, Langer R, Anderson DG. Materials for diabetes
therapeutics. Advanced Healthcare Materials. 2012;1:267–284.
Bratlie KM, York RL, Invernale MA, Langer R, Anderson DG. Materials for diabetes
therapeutics. Advanced Healthcare Materials. 2012;1:267–284.
Cash, Kevin J., and Heather A. Clark. "Nanosensors and nanomaterials for monitoring
glucose in diabetes." Trends in molecular medicine 16.12 (2010): 584-593.
Chang, S., He, J., Lin, L., Zhang, P., Liang, F., Young, M., ... & Lindsay, S. (2009). Tunnel
conductance of Watson–Crick nucleoside–base pairs from telegraph
noise. Nanotechnology, 20(18), 185102.
Chertok B, Webber MJ, Succi MD, Langer R. Drug Delivery Interfaces in the 21st
Century: From Science Fiction Ideas to Viable Technologies. Molecular
Pharmaceutics. 2013;10:3531–3543.
Clever, G. H., & Shionoya, M. (2010). Metal–base pairing in DNA. Coordination Chemistry
Reviews, 254(19-20), 2391-2402.
Dang TT, Thai AV, Cohen J, Slosberg JE, Siniakowicz K, Doloff JC, Ma M, Hollister-Lock
J, Tang KM, Gu Z, et al. Enhanced function of immuno-isolated islets in diabetes therapy
by co-encapsulation with an anti-inflammatory drug. Biomaterials. 2013;34:5792–5801
Daniel, M. C., & Astruc, D. (2004). Gold nanoparticles: assembly, supramolecular
chemistry, quantum-size-related properties, and applications toward biology, catalysis,
and nanotechnology. Chemical reviews, 104(1), 293-346.
Lorand JP, Edwards JO. Polyol Complexes and Structure of the Benzeneboronate
Ion. The Journal of Organic Chemistry. 1959;24:769–774
Mayfield, J. A. (1998). Diagnosis and classification of diabetes mellitus: new
criteria. American family physician, 58(6), 1355.
Mo, R., Jiang, T., Di, J., Tai, W., & Gu, Z. (2014). Emerging micro-and nanotechnology
based synthetic approaches for insulin delivery. Chemical Society Reviews, 43(10),
3595-3629.
Pickup JC, Zhi Z-L, Khan F, Saxl T, Birch DJS. Nanomedicine and its potential in diabetes
research and practice. Diabetes/Metabolism Research and Reviews. 2008;24:604–610.
Porter, A. L., Youtie, J., Shapira, P., & Schoeneck, D. J. (2008). Refining search terms
for nanotechnology. Journal of nanoparticle research, 10(5), 715-728.